Completed NA INTERVENTIONAL 1-arm NCT04202419

Nonablative Fractional Diode Laser for Treatment of Pigmented Lesions

Clinical Evaluation of a Nonablative Fractional 1940 nm Diode Laser for Treatment of Pigmented Lesions

Sponsor: Candela Corporation

Interventions FRAX 1940 nm laser

Updated 10 times since 2020 Last updated: Jul 13, 2023 Started: Jan 9, 2020 Primary completion: Apr 26, 2021 Completion: Apr 26, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Pigmented Skin Lesion, this trial is completed. The trial is conducted by Candela Corporation and has accumulated 10 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2023 — Jul 2024 [monthly]

Completed NA
Sep 2021 — Sep 2023 [monthly]

Completed NA
Jun 2021 — Sep 2021 [monthly]

Completed NA

Status: Withheld → Completed · Phase: None → NA

▶ Show 5 earlier versions

May 2021 — Jun 2021 [monthly]

Withheld
Jan 2021 — May 2021 [monthly]

Withheld
Aug 2020 — Jan 2021 [monthly]

Withheld
Feb 2020 — Aug 2020 [monthly]

Withheld
Jan 2020 — Feb 2020 [monthly]

Withheld

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Candela Corporation
Miami Dermatology and Laser Institute

Data source: Candela Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Miami, United States